The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPOView Video
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plantView Video

Latest Share Chat

Wednesday broker round-up - UPDATE

Wed, 22nd Feb 2012 09:32

Vodafone: Credit Suisse cuts target from 175p to 170p, outperform rating kept.Vedanta Resources: Credit Suisse maintains neutral rating and 1,400p target.AMEC: UBS raises target from 1,225p to 1,325p, buy rating unchanged; Nomura raises target from 1,130p to 1,240p, buy rating unchanged.HSBC: Nomura reiterates buy rating and 725p target.Standard Chartered: Nomura reiterates buy rating and 1,800p target.Barratt Developments: Panmure Gordon maintains buy rating and 158p target.Millennium & Copthorne: Credit Suisse reiterates outperform recommendation and 579p target; Nomura keeps neutral rating and 460p target; Panmure Gordon maintains sell rating and 343p target.Segro: Credit Suisse keeps outperform rating and 290p target.Logica: Merchant Securities maintains sell rating and 70p target.St. James's Place: Nomura keeps neutral rating and 330p target; Panmure Gordon raises target from 400p to 425p, buy rating kept.Galliford Try: Panmure Gordon raises target from 581p to 590p, buy rating kept.Filtrona: Panmure Gordon keeps hold rating and 408p target.Travis Perkins: Panmure Gordon reiterates buy rating and 1,050p target.BBA Aviation: UBS downgrades from buy to neutral, 220p target unchanged.Croda: UBS ups target from 2,085p to 2,250p, buy rating kept.Hutchison China Meditech: UBS downgrades from buy to neutral, 460p target unchanged.Misys: UBS ups target from 245p to 360p, neutral rating kept.

Related Shares

More News
1 May 2024 18:14

IN BRIEF: Malin Corp investee signs agreement with Astellas Pharma

Malin Corp PLC - Dublin-based investor in life sciences companies - Investee company Poseida Therapeutics Inc enters into a research collaboration and...

21 Mar 2024 14:59

UK shareholder meetings calendar - next 7 days

28 Feb 2024 17:31

EARNINGS: Hutchmed revenue surges, Craven House's loss widens

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

26 Jan 2024 14:30

TRADING UPDATES: Puma and Puma Alpha invest in Not Another Beer

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

27 Oct 2023 15:17

IN BRIEF: Malin confirms new executive director joins board

Malin Corp PLC - Dublin-based investor in life sciences companies - Confirms that Fiona Dunlevy joins the board as an executive director. Outgoing Chi...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.